EGR1 expression: A calcium and ERK1/2 mediated PPARγ- independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells

Biochemical Pharmacology

Volumn 81, Issue 9, 2011, Pages 1087-1097

  Chbicheb, Sarra ^a   Yao, Xiao ^a   Rodeau, Jean Luc ^b   Salamone, Stéphane ^c,e   Boisbrun, Michel ^c   Thiel, Gerald ^d   Spohn, Daniel ^d   Grillier Vuissoz, Isabelle ^a   Chapleur, Yves ^c   Flament, Stéphane ^a   Mazerbourg, Sabine ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b IFR 37 des Neurosciences de Strasbourg   (France)

^c NANCY UNIVERSITÉ   (France)

^d SAARLAND UNIVERSITY   (Germany)

^e INSTITUT PASTEUR   (France)

Author keywords

Breast cancer; Calcium signaling; EGR1; Thiazolidinedione; Troglitazone

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; CALCIUM; CIGLITAZONE; EARLY GROWTH RESPONSE FACTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TROGLITAZONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; ENZYME PHOSPHORYLATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS;

BASE SEQUENCE; BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PPAR GAMMA; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLIDINEDIONES;

EID: 79953709985     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.02.006     Document Type: Article

References (48)

1. L. Michalik, J. Auwerx, J.P. Berger, V.K. Chatterjee, C.K. Glass, and F.J. Gonzalez International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacol Rev 58 2006 726 741 (Pubitemid 44833742)
2. W.W. Cheatham Peroxisome proliferator-activated receptor translational research and clinical experience Am J Clin Nutr 91 2010 262S 266S
3. C. Blanquicett, J. Roman, and C.M. Hart Thiazolidinediones as anti-cancer agents Cancer Ther 6 2008 25 34
4. H.P. Koeffler Peroxisome proliferator-activated receptor gamma and cancers Clin Cancer Res 9 2003 1 9 (Pubitemid 36109710)
5. M.H. Fenner, and E. Elstner Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer Expert Opin Investig Drugs 14 2005 557 568 (Pubitemid 40895186)
6. K.Y. Kim, S.S. Kim, and H.G. Cheon Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells Biochem Pharmacol 72 2006 530 540 (Pubitemid 44163294)
7. R. Kar, P.K. Singha, M.A. Venkatachalam, and P. Saikumar A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells Oncogene 28 2009 2556 2568
8. J. Zhou, W. Zhang, B. Liang, M.C. Casimiro, D. Whitaker-Menezes, and M. Wang PPARgamma activation induces autophagy in breast cancer cells Int J Biochem Cell Biol 41 2009 2334 2342
9. S. Wei, J. Yang, S.L. Lee, S.K. Kulp, and C.S. Chen PPARgamma-independent antitumor effects of thiazolidinediones Cancer Lett 276 2009 119 124
10. J. Lecomte, S. Flament, S. Salamone, M. Boisbrun, S. Mazerbourg, and Y. Chapleur Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines Breast Cancer Res Treat 112 2008 437 451
11. J.W. Huang, C.W. Shiau, Y.T. Yang, S.K. Kulp, K.F. Chen, and R.W. Brueggemeier Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells Mol Pharmacol 67 2005 1342 1348 (Pubitemid 40410435)
12. C. Colin, S. Salamone, I. Grillier-Vuissoz, M. Boisbrun, S. Kuntz, and J. Lecomte New troglitazone derivatives devoid of PPARgamma agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines Breast Cancer Res Treat 124 2010 101 110
13. S.J. Baek, L.C. Wilson, L.C. Hsi, and T.E. Eling Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity J Biol Chem 278 2003 5845 5853 (Pubitemid 36800831)
14. V.P. Sukhatme, X.M. Cao, L.C. Chang, C.H. Tsai-Morris, D. Stamenkovich, and P.C. Ferreira A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization Cell 53 1988 37 43
15. A.H. Swirnoff, and J. Milbrandt DNA-binding specificity of NGFI-A and related zinc finger transcription factors Mol Cell Biol 15 1995 2275 2287
16. V. Baron, G. De Gregorio, A. Krones-Herzig, T. Virolle, A. Calogero, and R. Urcis Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo Oncogene 22 2003 4194 4204 (Pubitemid 36876240)
17. J.W. Huang, C.W. Shiau, J. Yang, D.S. Wang, H.C. Chiu, and C.Y. Chen Development of small-molecule cyclin D1-ablative agents J Med Chem 49 2006 4684 4689 (Pubitemid 44162695)
18. J. Liu, Y.G. Liu, R. Huang, C. Yao, S. Li, and W. Yang Concurrent down-regulation of Egr-1 and gelsolin in the majority of human breast cancer cells Cancer Genomics Proteomics 4 2007 377 385
19. R.P. Huang, C. Liu, Y. Fan, D. Mercola, and E.D. Adamson Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain Cancer Res 55 1995 5054 5062
20. D. Boschi, G.C. Tron, L. Lazzarato, K. Chegaev, C. Cena, and A. Di Stilo NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties J Med Chem 49 2006 2886 2897
21. J. Kumbrink, M. Gerlinger, and J.P. Johnson Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop J Biol Chem 280 2005 42785 42793 (Pubitemid 43049240)
22. M. Cippitelli, C. Fionda, D. Di Bona, A. Lupo, M. Piccoli, and L. Frati The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma- independent mechanisms J Immunol 170 2003 4578 4592 (Pubitemid 36519964)
23. G. Thiel, and G. Cibelli Regulation of life and death by the zinc finger transcription factor Egr-1 J Cell Physiol 193 2002 287 292 (Pubitemid 35265949)
24. + exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7 Cell Physiol Biochem 20 2007 751 762 (Pubitemid 350059719)
25. F. Yin, D. Bruemmer, F. Blaschke, W.A. Hsueh, R.E. Law, and A.J. Herle Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells Oncogene 23 2004 4614 4623 (Pubitemid 38850409)
26. X. Li, X. Yang, Y. Xu, X. Jiang, F. Nan, and H. Tang Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma Cell Res 19 2009 720 732
27. O.S. Gardner, C.W. Shiau, C.S. Chen, and L.M. Graves Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress J Biol Chem 280 2005 10109 10118 (Pubitemid 40395863)
28. B.J. Dewar, O.S. Gardner, C.S. Chen, H.S. Earp, J.M. Samet, and L.M. Graves Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones Mol Pharmacol 72 2007 1146 1156 (Pubitemid 350012589)
29. A.M. Lennon, M. Ramauge, A. Dessouroux, and M. Pierre MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)- prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species J Biol Chem 277 2002 29681 29685
30. O.S. Gardner, B.J. Dewar, and L.M. Graves Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling Mol Pharmacol 68 2005 933 941 (Pubitemid 41345784)
31. C. Zang, H. Liu, J. Bertz, K. Possinger, H.P. Koeffler, and E. Elstner Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells Mol Cancer Ther 8 2009 2296 2307
32. M. Sakaue, H. Adachi, M. Dawson, and A.M. Jetten Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2 Cell Death Differ 8 2001 411 424 (Pubitemid 32409612)
33. Y. Moon, H. Yang, and Y.B. Kim Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells Toxicol Appl Pharmacol 223 2007 155 163 (Pubitemid 47348058)
34. A. Orellana, L. Holuigue, P.C. Hidalgo, V. Faundez, A. Gonzalez, and M. Bronfman Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes Eur J Biochem 215 1993 903 906 (Pubitemid 23246867)
35. C.J. Pauley, B.J. Ledwith, and C. Kaplanski Peroxisome proliferators activate growth regulatory pathways largely via peroxisome proliferator- activated receptor alpha-independent mechanisms Cell Signal 14 2002 351 358 (Pubitemid 34164690)
36. O.S. Gardner, B.J. Dewar, H.S. Earp, J.M. Samet, and L.M. Graves Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation J Biol Chem 278 2003 46261 46269 (Pubitemid 37452196)
37. K. Subik, J.F. Lee, L. Baxter, T. Strzepek, D. Costello, and P. Crowley The expression patterns of eR, Pr, HeR2, cK5/6, eGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell Lines Breast Cancer: Basic and Clinical Research 4 2010 35 41
38. S.S. Palakurthi, H. Aktas, L.M. Grubissich, R.M. Mortensen, and J.A. Halperin Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation Cancer Res 61 2001 6213 6218 (Pubitemid 32762559)
39. B. Chopra, N.T. Georgopoulos, A. Nicholl, J. Hinley, M.B. Oleksiewicz, and J. Southgate Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels Cell Prolif 42 2009 688 700
40. S.I. Mayer, and G. Thiel Calcium influx into MIN6 insulinoma cells induces expression of Egr-1 involving extracellular signal-regulated protein kinase and the transcription factors Elk-1 and CREB Eur J Cell Biol 88 2009 19 33
41. D. Gitenay, and V.T. Baron Is EGR1 a potential target for prostate cancer therapy? Future Oncol 5 2009 993 1003
42. S.H. Lee, J.H. Bahn, C.K. Choi, N.C. Whitlock, A.E. English, and S. Safe ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells Mol Cancer Ther 7 2008 3739 3750
43. J. Yu, V. Baron, D. Mercola, T. Mustelin, and E.D. Adamson A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells Cell Death Differ 14 2007 436 446
44. C.J. Li, W. Ning, M.A. Matthay, C.A. Feghali-Bostwick, and A.M. Choi MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production Am J Physiol Lung Cell Mol Physiol 292 2007 L1297 L1303
45. L.L. Gutierrez, A. Maslinkiewicz, R. Curi, and P.I. de Bittencourt Jr. Atherosclerosis: a redox-sensitive lipid imbalance suppressible by cyclopentenone prostaglandins Biochem Pharmacol 75 2008 2245 2262
46. J.O. Ban, D.H. Kwak, J.H. Oh, E.J. Park, M.C. Cho, and H.S. Song Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone Chem Biol Interact 188 2010 75 85
47. S.H. Liang, W. Zhang, B.C. McGrath, P. Zhang, and D.R. Cavener PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis Biochem J 393 2006 201 209 (Pubitemid 43049316)
48. S. Muthukkumar, P. Nair, S.F. Sells, N.G. Maddiwar, R.J. Jacob, and V.M. Rangnekar Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6 Mol Cell Biol 15 1995 6262 6272